These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35242737)

  • 21. Erratum: Thirty years of research on physical activity, mental health, and wellbeing: A scientometric analysis of hotspots and trends.
    Frontiers Production Office
    Front Public Health; 2023; 11():1178895. PubMed ID: 36998283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution of health social security expenditure in Chile: A review of financial aggregates from 2000 to 2018].
    Lenz-Alcayaga R; Páez-Pizarro L
    Medwave; 2021 Feb; 21(1):e8117. PubMed ID: 33755037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equity in health personnel financing after Universal Coverage: evidence from Thai Ministry of Public Health's hospitals from 2008-2012.
    Ruangratanatrai W; Lertmaharit S; Hanvoravongchai P
    Hum Resour Health; 2015 Jul; 13():59. PubMed ID: 26187375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How were situations of preventive and curative care expenditure for AIDS and medical burden of patients? Research based on "System of Health Accounts 2011".
    Zhan H; Wu Q; Zang S; Zhou L; Wang X
    BMC Public Health; 2020 Feb; 20(1):169. PubMed ID: 32019506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substitute services: a barrier to controlling long-term care expenditures.
    Kattenberg M; Bakx P
    Eur J Ageing; 2021 Mar; 18(1):85-97. PubMed ID: 33746684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [FINANCING OF MEDICINES FOR TREATMENT OF RARE DISEASES OF THE NERVOUS SYSTEM. ORPHAN DRUGS IN RARE NEUROLOGICAL DISEASES].
    Szegedi Márta ; Kosztolányi G; Boncz I; Molnár MJ
    Ideggyogy Sz; 2016 Jan; 69(1-2):37-45. PubMed ID: 26987239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyprus health system review.
    Theodorou M; Charalambous C; Petrou C; Cylus J
    Health Syst Transit; 2012; 14(6):1-128. PubMed ID: 23149260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Healthcare expenditure].
    Huguier M
    Bull Acad Natl Med; 2012 Oct; 196(7):1443-9. PubMed ID: 23815025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of changes in private health expenditure on New Zealand households.
    Hopkins S; Cumming J
    Health Policy; 2001 Dec; 58(3):215-29. PubMed ID: 11641000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rajiv Aarogyasri Community Health Insurance Scheme in Andhra Pradesh, India: a comprehensive analytic view of private public partnership model.
    Reddy S; Mary I
    Indian J Public Health; 2013; 57(4):254-9. PubMed ID: 24351388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Willingness to Pay for a Contributory National Health Insurance Scheme in Saudi Arabia: A Cross-sectional Stated Preference Approach.
    Al-Hanawi MK; Vaidya K; Alsharqi O; Onwujekwe O
    Appl Health Econ Health Policy; 2018 Apr; 16(2):259-271. PubMed ID: 29307076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Turkey. Health system review.
    Tatar M; Mollahaliloğlu S; Sahin B; Aydin S; Maresso A; Hernández-Quevedo C
    Health Syst Transit; 2011; 13(6):1-186, xiii-xiv. PubMed ID: 22455830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erratum: The effects of non-pharmaceutical interventions on COVID-19 mortality: A generalized synthetic control approach across 169 countries.
    Frontiers Production Office
    Front Public Health; 2023; 11():1186935. PubMed ID: 37050941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the activity levels and financing sources of Israel's private for-profit hospitals in the wake of reforms to the public-private divide.
    Barnea R; Niv-Yagoda A; Weiss Y
    Isr J Health Policy Res; 2021 Mar; 10(1):23. PubMed ID: 33722281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Public expenditure caused by the consumption of illicit drugs in Germany].
    Mostardt S; Flöter S; Neumann A; Wasem J; Pfeiffer-Gerschel T
    Gesundheitswesen; 2010 Dec; 72(12):886-94. PubMed ID: 20066613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bulgaria health system review.
    Dimova A; Rohova M; Moutafova E; Atanasova E; Koeva S; Panteli D; van Ginneken E
    Health Syst Transit; 2012; 14(3):1-186. PubMed ID: 22894828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of micro health insurance on financial protection: Evidence from India.
    Savitha S; Kiran KB
    Int J Health Econ Manag; 2015 Mar; 15(1):53-71. PubMed ID: 27878668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sharing in the financing of health care: government, insurance and the patient.
    Ron A
    Health Policy; 1986; 6(1):87-101. PubMed ID: 10276318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.